From GlobeNewswire: 2024-12-13 09:18:00

The global Epilepsy Device Market was valued at $0.75 billion in 2023, expected to reach $1.18 billion by 2032 with a CAGR of 5.15%. Rising global epilepsy prevalence is driving demand for advanced diagnostic tools and treatment options, including non-invasive technologies like RNS and TMS, with AI playing a key role in transforming care.

Hospitals lead the epilepsy device market, capturing 69% of revenue in 2023, while Neurology Centers are projected to grow at a CAGR of 6.56% from 2024 to 2032 due to increasing demand for specialized neurological care. Conventional Devices currently dominate the market, but Wearable Devices are expected to drive future growth.

Deep Brain Stimulation (DBS) currently leads the epilepsy device market, while Responsive Neurostimulation (RNS) shows promising growth potential with a projected CAGR of 4.23% from 2024 to 2032. North America leads the market, while Asia Pacific is projected to grow the fastest at a CAGR of 6.93% due to increasing awareness and healthcare investments.

On January 8, 2024, Medtronic announced that its Percept RC Deep Brain Stimulation (DBS) system received U.S. approval, showcasing ongoing developments in the epilepsy device market. LivaNova will present new data on the effectiveness of its Vagus Nerve Stimulation (VNS) Therapy for drug-resistant epilepsy at the American Epilepsy Society (AES) Annual Meeting on December 11, 2024. The FDA-approved therapy is showing promising results in treating epilepsy.

A comprehensive Epilepsy Device Market Analysis & Outlook Report for 2024-2032 is available for purchase. The report includes key points such as market dynamics impact analysis, patient compliance trends, regional device volume data, and competitive landscape insights. Various buying options are offered, including reports packs and subscriptions.

SNS Insider is a leading market research and consulting agency offering valuable insights for clients to navigate changing market conditions. Through surveys, video talks, and focus groups, the company provides accurate market data, consumer insights, and opinions. The aim is to empower clients to make informed decisions with confidence based on current market trends.



Read more at GlobeNewswire: Epilepsy Device Market to Reach USD 1.18 Billion by 2032,